CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020

Filetype[PDF-389.24 KB]


English
Details Supporting Files You May Also Like

Details:

  • Alternative Title:
    MMWR Recommendations and Reports
  • Journal Article:
    MMWR. Recommendations and Reports
  • Personal Author:
    Sarah Schillie; Carolyn Wester; Melissa Osborne; Laura Wesolowski et al.
  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
  • Description:
    Hepatitis C Virus (HCV) infection is a major source of morbidity and Mortality in the United States HCV is transmitted primarily through parenteral exposures to infectious blood or body fluids that contain blood, most commonly through injection drug use. No vaccine against hepatitis C exists and no effective pre- or postexposure prophylaxis is available. More than half of persons who become infected with HCV will develop chronic infection. Direct-acting antiviral treatment can result in a virologic cure in most persons with 8–12 weeks of all-oral medication regimens. This report augments (i.e., updates and summarizes) previously published recommendations from CDC regarding tTesting for HCV infection in the United States (Smith BD, Morgan RL, Beckett GA, et al. Recommendations for the identification of chronic hepatitis C Virus infection among persons born during 1945–1965. MMWR Recomm Rec 2012;61[No. RR-4]). CDC is augmenting previous guidance with two new recommendations: 1) hepatitis C screening at least once in a lifetime for all adults aged ≥18 years, except in settings where the prevalence of HCV infection is <0.1% and 2) hepatitis C screening for all pregnant women during each pregnancy, except in settings where the prevalence of HCV infection is <0.1%. The recommendation for HCV tTesting that remains unchanged is regardless of age or setting prevalence, all persons with risk factors should be tested for hepatitis C, with periodic tTesting while risk factors persist. Any person who requests hepatitis C tTesting should receive it, regardless of disclosure of risk, because many persons might be reluctant to disclose stigmatizing risks.
  • Source:
    Recommendations and Reports / April 10, 2020 / 69(2);1–17
  • Series:
    MMWR. Recommendations and reports: Morbidity and Mortality Weekly Report. Recommendations and Reports / April 10, 2020 / 69(2);1–17
  • Document Type:
    Journal Issue
  • Place as Subject:
    United States
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

You May Also Like

Checkout today's featured content at stacks.cdc.gov